Table 3. Response to cetuximab-based regimens and to single agent panitumumab (N = 30).
Response | Cetuximab-based regimens | Single agent panitumumab | ||
---|---|---|---|---|
No | % | No | % | |
Complete response (CR) | 1 | 3 | 0 | 0 |
Partial response (PR) | 17 | 57 | 9 | 30 |
Stable disease (SD) | 12 | 40 | 11 | 37 |
Progressive disease (PD) | 0 | 0 | 10 | 33 |
Disease control rate (CR + PR + SD) | 100 | 20 | 67 |